* Pulmonx Corp LUNG.OQ reported a quarterly adjusted loss
of 35
cents per share for the quarter ended in December. The mean
expectation of six analysts for the quarter was for a loss of 36
cents per share.
* Revenue rose 39.5% to $13.71 million from a year ago;
analysts
expected $14.24 million.
* Pulmonx Corp's reported EPS for the quarter was a loss
of 35
cents.
* The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Pulmonx Corp shares had fallen by 18.1% this quarter.
* The company reported a quarterly loss of $13.01 million.
* Wall Street's median 12-month price target for Pulmonx
Corp is
$36.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated February 24 at 05:36 p.m.
All figures in US dollars unless otherwise stated